Columbia Laboratories, Inc. (NASDAQ: CBRX) reported Q4 EPS of $0.08, versus $0.17 reported last year. Revenue for the quarter came ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE